CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 13351-13352 [2017-04742]
Download as PDF
<![CDATA[
13351
Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
INSTITUTIONS IN LIQUIDATION
[In alphabetical order]
FDIC ref. No.
Bank name
City
10525 ................
Proficio Bank ........................................................
Cottonwood Heights .............................................
OMB No.: 0970–0157.
Description: 42 U.S.C. 612 (Section
412 of the Social Security Act) requires
each Indian Tribe that elects to
administer and operate a TANF program
to submit a TANF Tribal Plan. The
TANF Tribal Plan is a mandatory
statement submitted to the Secretary by
the Indian Tribe, which consists of an
outline of how the Indian Tribes TANF
program will be administered and
operated. It is used by the Secretary to
determine whether the plan is
[FR Doc. 2017–04730 Filed 3–9–17; 8:45 am]
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Guidance for Tribal TANF.
State
UT
Date closed
3/3/2017
approvable and to determine that the
Indian Tribe is eligible to receive a
TANF assistance grant. It is also made
available to the public.
Respondents: Indian Tribes applying
to operate a TANF program.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total
burden
hours
Request for State Data Needed to Determine the Amount of a Tribal Family
Assistance Grant ..........................................................................................
sradovich on DSK3GMQ082PROD with NOTICES
Instrument
24
1
68
1,632
Estimated Total Annual Burden
Hours: 1,632.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 330
C Street SW., Washington, DC 20201.
Attention Reports Clearance Officer. All
requests should be identified by the title
of the information collection. Email
address: infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2017–04752 Filed 3–9–17; 8:45 am]
BILLING CODE 4184–01–P
VerDate Sep<11>2014
18:37 Mar 09, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment
Health Resources and Services
Administration, Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of meeting.
In accordance with the
Federal Advisory Committee Act, notice
is hereby given that a meeting is
scheduled for the Centers for Disease
Control and Prevention (CDC)/Health
Resources and Services Administration
(HRSA) Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment. This meeting will be open to
the public. Information about the CDC/
HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment and the meeting agenda can
be obtained by contacting CDR Holly
Berilla at (301) 443–9965 or hberilla@
hrsa.gov.
SUMMARY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
The meeting will be held on
March 30, 2017, from 2:00 p.m. to 3:00
p.m. (Eastern).
ADDRESSES: The meeting will be held
virtually with telephone access that will
accommodate up to 100 attendees and is
open to the public. Parties may access
the teleconference by dialing 888–566–
6570 and using participant code:
1682061. Participants should call and
connect 15 minutes prior to the start of
the meeting.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment should
contact CDR Holly Berilla, Public Health
Analyst, HRSA, HIV/AIDS Bureau
(HAB), Division of Policy and Data
(DPD), in one of three ways: (1) Send a
request to the following address: CDR
Holly Berilla, Public Health Analyst,
HRSA, HAB, DPD, 5600 Fishers Lane,
Rockville, Maryland 20857; (2) call 301–
443–9965; or (3) send an email to
hberilla@hrsa.gov.
SUPPLEMENTARY INFORMATION: The CDC/
HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment was established under
Section 222 of the Public Health Service
DATES:
E:\FR\FM\10MRN1.SGM
10MRN1
13352
Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices
Act (42 U.S.C. Section 217a), as
amended.
The purpose of the CDC/HRSA
Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and
Treatment is to advise the Secretary of
HHS, the Director of CDC, and the
Administrator of HRSA regarding
objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and
other STDs; prevention and treatment
efforts including surveillance of HIV
infection, AIDS, viral hepatitis, and
other STDs, and related behaviors;
epidemiologic, behavioral, health
services, and laboratory research on
HIV/AIDS, viral hepatitis, and other
STDs; identification of policy issues
related to HIV/viral hepatitis/STD
professional eduction, patient
healthcare delivery, and prevention
services; HHS policies about prevention
of HIV/AIDS, viral hepatitis and other
STDs; treatment, healthcare delivery,
and research and training; strategic
issues influencing the ability of CDC
and HRSA to fulfill their missions of
providing prevention and treatment
services; programmatic efforts to
prevent and treat HIV, viral hepatitis,
and other STDs; and support to CDC
and HRSA in their developoment of
responses to emerging health needs
related to HIV, viral hepatitis, and other
STDs.
During the March 30, 2017 meeting,
the CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment will deliberate and vote
on a proposed resolution regarding the
HIV workforce, a proposal to expand the
existing HCV (hepatitis C virus)
Workgroup, and a proposal to develop
an HIV Disparities Workgroup. Agenda
items are subject to change as priorities
dictate.
Due to the nature and time limitations
of the meeting, members of the public
will not have an opportunity to provide
oral comments. Individuals who need
reasonable accommodations should
notify CDR Holly Berilla at hberilla@
hrsa.gov at least 10 days prior to the
meeting.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017–04742 Filed 3–9–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
[Document Identifier: 0990–0324–30D]
Agency Information Collection
Activities; Submission to OMB for
Review and Approval; Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, has submitted an
Information Collection Request (ICR),
described below, to the Office of
Management and Budget (OMB) for
review and approval. The ICR is for
reinstatement of a previously-approved
SUMMARY:
information collection assigned OMB
control number 0990–0324, which
expired on March 31, 2011. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public on this ICR during the review
and approval period.
DATES: Comments on the ICR must be
received on or before April 10, 2017.
ADDRESSES: Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 690–5683.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the OMB
control number 0990–0324 for
reference.
Information Collection Request Title:
The Commissioned Corps of the U.S.
Public Health Service Application—
Medical Forms.
Abstract: The principal purpose for
collecting the information is to permit
HHS to determine eligibility for
appointment of applicants into the
Commissioned Corps of the U.S. Public
Health Service (Corps). The Corps is one
of the seven Uniformed Services of the
United States (37 U.S.C. 101(3)), and
appointments in the Corps are made
pursuant to 42 U.S.C. 204 et seq. and 42
CFR 21.58. The application consists of
PHS Medical forms noted below.
Likely Respondents: Candidates/
Applicants to the Commissioned Corps.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form No.
Total burden
hours
........................................................................................
........................................................................................
........................................................................................
........................................................................................
........................................................................................
........................................................................................
........................................................................................
........................................................................................
1,000
4,000
800
1,320
2,800
1,600
600
2,000
1
1
1
1
1
1
1
1
1
30/60
6/60
6/60
7/60
7/60
5/60
10/60
1,000
2,000
80
132
327
187
50
333
Total ..........................................................................................
sradovich on DSK3GMQ082PROD with NOTICES
PHS–6355
PHS–6379
PHS–7053
PHS–7054
PHS–7055
PHS–7056
PHS–7057
PHS–7061
Average
burden hour
per response
(within 1 hour)
Response per
respondent
............................
............................
............................
4,109
Terry S. Clark,
Asst Information Collection Clearance
Officer.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–04612 Filed 3–9–17; 8:45 am]
National Committee on Vital and Health
Statistics: Teleconference
BILLING CODE 4150–49–P
Pursuant to the Federal Advisory
Committee Act, the Department of
Health and Human Services (HHS)
VerDate Sep<11>2014
18:37 Mar 09, 2017
Jkt 241001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
announces the following advisory
committee meeting to be held virtually.
Name: National Committee on Vital
and Health Statistics (NCVHS), Full
Committee Virtual Meeting.
Dates and Times: Tuesday, April 18,
2017: 3:00 p.m.–5:00 p.m. (EDT).
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 82, Number 46 (Friday, March 10, 2017)]
[Notices]
[Pages 13351-13352]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04742]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment
AGENCY: Health Resources and Services Administration, Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, notice
is hereby given that a meeting is scheduled for the Centers for Disease
Control and Prevention (CDC)/Health Resources and Services
Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment. This meeting will be open to the public.
Information about the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment and the meeting agenda can
be obtained by contacting CDR Holly Berilla at (301) 443-9965 or
hberilla@hrsa.gov.
DATES: The meeting will be held on March 30, 2017, from 2:00 p.m. to
3:00 p.m. (Eastern).
ADDRESSES: The meeting will be held virtually with telephone access
that will accommodate up to 100 attendees and is open to the public.
Parties may access the teleconference by dialing 888-566-6570 and using
participant code: 1682061. Participants should call and connect 15
minutes prior to the start of the meeting.
FOR FURTHER INFORMATION CONTACT: Anyone requesting information
regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment should contact CDR Holly Berilla, Public
Health Analyst, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and
Data (DPD), in one of three ways: (1) Send a request to the following
address: CDR Holly Berilla, Public Health Analyst, HRSA, HAB, DPD, 5600
Fishers Lane, Rockville, Maryland 20857; (2) call 301-443-9965; or (3)
send an email to hberilla@hrsa.gov.
SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and Treatment was established under
Section 222 of the Public Health Service
[[Page 13352]]
Act (42 U.S.C. Section 217a), as amended.
The purpose of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment is to advise the Secretary
of HHS, the Director of CDC, and the Administrator of HRSA regarding
objectives, strategies, policies, and priorities for HIV, viral
hepatitis, and other STDs; prevention and treatment efforts including
surveillance of HIV infection, AIDS, viral hepatitis, and other STDs,
and related behaviors; epidemiologic, behavioral, health services, and
laboratory research on HIV/AIDS, viral hepatitis, and other STDs;
identification of policy issues related to HIV/viral hepatitis/STD
professional eduction, patient healthcare delivery, and prevention
services; HHS policies about prevention of HIV/AIDS, viral hepatitis
and other STDs; treatment, healthcare delivery, and research and
training; strategic issues influencing the ability of CDC and HRSA to
fulfill their missions of providing prevention and treatment services;
programmatic efforts to prevent and treat HIV, viral hepatitis, and
other STDs; and support to CDC and HRSA in their developoment of
responses to emerging health needs related to HIV, viral hepatitis, and
other STDs.
During the March 30, 2017 meeting, the CDC/HRSA Advisory Committee
on HIV, Viral Hepatitis and STD Prevention and Treatment will
deliberate and vote on a proposed resolution regarding the HIV
workforce, a proposal to expand the existing HCV (hepatitis C virus)
Workgroup, and a proposal to develop an HIV Disparities Workgroup.
Agenda items are subject to change as priorities dictate.
Due to the nature and time limitations of the meeting, members of
the public will not have an opportunity to provide oral comments.
Individuals who need reasonable accommodations should notify CDR Holly
Berilla at hberilla@hrsa.gov at least 10 days prior to the meeting.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017-04742 Filed 3-9-17; 8:45 am]
BILLING CODE 4165-15-P
